{"created":"2023-07-27T06:39:28.351344+00:00","id":27932,"links":{},"metadata":{"_buckets":{"deposit":"90ce1c07-d4a2-4c0a-92f3-2b3fea9fbfd0"},"_deposit":{"created_by":3,"id":"27932","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"27932"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00027932","sets":["1777:1780:1800:1801"]},"author_link":["1497"],"item_9_alternative_title_2":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"マウスモデルを用いた消化器がんの発がん分子機序に関する基礎研究"}]},"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2011-04-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2010","bibliographicPageEnd":"27","bibliographicPageStart":"26","bibliographicVolumeNumber":"平成22年度","bibliographic_titles":[{"bibliographic_title":"金沢大学がん研究所 共同研究成果報告書"}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"癌幹細胞表面マーカーである接着分子CD44 がシスチントランスポーターxCT と結合する ことで癌細胞内の活性酸素の蓄積を抑制し、腫瘍の増大と治療抵抗性を促進する分子機構につ いて胃癌自然発症モデルK19-Wnt1/C2mE トランスジェニックマウスを用いて解明した。今回 の研究成果により、治療抵抗性を有するCD44 陽性癌幹細胞をターゲットとした新たな治療法 の開発が期待できると考えられる。","subitem_description_type":"Abstract"}]},"item_9_publisher_17":{"attribute_name":"公開者","attribute_value_mlt":[{"subitem_publisher":"金沢大学がん研究所 = Cancer Research Institute of Kanazawa University"}]},"item_9_relation_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"BA90820956","subitem_relation_type_select":"NCID"}}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.kanazawa-u.ac.jp/~ganken/","subitem_relation_type_select":"URI"}}]},"item_9_rights_23":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright © Cancer Research Institute of Kanazawa University"}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-05"}],"displaytype":"detail","filename":"CA-com-report-2010-26-27.pdf","filesize":[{"value":"402.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"CA-com-report-2010-26-27.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/27932/files/CA-com-report-2010-26-27.pdf"},"version_id":"e04a4b9e-831e-4d23-8245-84c642e3a553"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"消化器がんにおけるCD44 の発現意義および治療抵抗性の分子機構","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"消化器がんにおけるCD44 の発現意義および治療抵抗性の分子機構"}]},"item_type_id":"9","owner":"3","path":["1801"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-05"},"publish_date":"2017-10-05","publish_status":"0","recid":"27932","relation_version_is_last":true,"title":["消化器がんにおけるCD44 の発現意義および治療抵抗性の分子機構"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-07-27T21:00:25.031038+00:00"}